Mira Pharmaceuticals Inc
NASDAQ:MIRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mira Pharmaceuticals Inc
NASDAQ:MIRA
|
US |
|
K
|
Kojamo Oyj
OMXH:KOJAMO
|
FI |
Income Statement
Earnings Waterfall
Mira Pharmaceuticals Inc
Income Statement
Mira Pharmaceuticals Inc
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Interest Expense |
0
|
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(9)
|
(13)
|
(9)
|
(9)
|
(10)
|
(9)
|
(8)
|
(8)
|
(8)
|
(7)
|
(10)
|
|
| Selling, General & Administrative |
(7)
|
(9)
|
(7)
|
(7)
|
(7)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(9)
|
|
| Research & Development |
(3)
|
(4)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
|
| Operating Income |
(9)
N/A
|
(13)
-34%
|
(9)
+32%
|
(9)
-5%
|
(10)
-8%
|
(9)
+11%
|
(8)
+7%
|
(8)
0%
|
(8)
+2%
|
(7)
+10%
|
(10)
-48%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
(0)
|
(1)
|
(3)
|
(3)
|
(3)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(10)
N/A
|
(13)
-37%
|
(12)
+10%
|
(12)
-3%
|
(13)
-3%
|
(11)
+12%
|
(8)
+30%
|
(8)
-1%
|
(8)
+2%
|
(7)
+12%
|
(10)
-52%
|
|
| Net Income | ||||||||||||
| Income from Continuing Operations |
(10)
|
(13)
|
(12)
|
(12)
|
(13)
|
(11)
|
(8)
|
(8)
|
(8)
|
(7)
|
(10)
|
|
| Net Income (Common) |
(10)
N/A
|
(13)
-37%
|
(12)
+10%
|
(12)
-3%
|
(13)
-3%
|
(11)
+12%
|
(8)
+30%
|
(8)
-1%
|
(8)
+2%
|
(28)
-266%
|
(32)
-13%
|
|
| EPS (Diluted) |
-0.66
N/A
|
-0.97
-47%
|
-0.81
+16%
|
-0.62
+23%
|
-0.86
-39%
|
-0.73
+15%
|
-0.51
+30%
|
-0.47
+8%
|
-0.45
+4%
|
-1.47
-227%
|
-1.35
+8%
|
|